Companies / Turkey
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Actavis Launching New Generics
October 2006 | Product LaunchSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Icelandic drugmaker Actavis has launched three new generic drugs in Turkey, as the company continues to expand in the country. The three products include Xetanor (paroxetine), an antidepressant in SSRI class, as well as the hypertension treatment Blockace (ramipiril) and the antihistamine Vivafeks (Fexofenadine).